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ABSRACT
Background:Stroke in pediatric population is increasingly recognized and has diverse clinical presentation and risk factor 
profile. Majority of patients survive acute stroke but remain disabled. The reported literature on the subject from our part of 
world is scarce.Methods:A retrospective chart review was carried out for stroke patients between 1 month and 14 years of 
age, admitted between January 2009 and January 2015. Their demographic, clinical and radiological data was collected 
and analyzed.Results:Twenty nine patients were admitted with stroke over 5 years. Their mean age was 5.7 ±11.7 and 
male to female ratio was 3:1. The most common clinical features reported were seizures (72%), paresis (62%), and altered 
mental status (52%) followed by fever (38%), cranial nerve palsies (34%) and vomiting (35%). Cardiovascular diseases 
(28%) were the most common identifiable etiologic factors. Only 59% had unilateral strokes. Fifty five percent had anterior 
circulation strokes, 14% had posterior circulation strokes while 31% had involvement of both vascular territories. Only 31% 
had single vessel strokes. Twenty-eight percent of the patient died during the hospital stay (mean stay was 7±5 days). 62% 
of the infants compared to 18% of older kids (p=0.01), 62% of patients with both vascular territories compared 15% in 
single territory (p=0.03) and 58% of patients with bilateral strokes compared to 6% in unilateral strokes (p=0.03) 
died.Conclusions: Cardiovascular diseases are most common etiologic factors of stroke in pediatric age group and it carries 
high acute mortality. Bilateral and multiple territorial strokes, and age less than one year were associated with acute 
mortality.
Introduction:
Stroke is debilitating disease which has been increasingly 
recognized in children in recent years, but diagnosis and 
management can be difficult because of the diversity of 
underlying risk factors and the absence of a uniform treatment 
approach.1The incidence of ischemic stroke in USA ranges 
from 0.56 to 2.4 per 100,000 children per year.4In the 
Paediatric population, ischemic stroke occurs in 55% of all 
strokes, the rest being hemorrhagic4, 5. In Contrary to adults 
in whom ischemic stroke comprises 80% to 85% of all the 
strokes cases.4, 5 Though hemiplegia is most common 
clinical presentation in pediatric stroke as in adults but seizures 
and fever are more common in pediatric strokes which 
affecting 27% and 23% respectively of pediatric stroke 
patient.6 Even when stroke presents acutely, delay in 
diagnosis is common, limiting the opportunities for timely 
interventions to improve outcome.4 Thrombolysis is standard 
of care for acute ischemic stroke in adult patients which is to 
be given within 4.5 hours of stroke onset7. Though the 
experience of thrombolysis in pediatric stroke is limited but it 
has to be given early8.However, it has been reported that in 
about 1/3 of children with stroke present for medical 
evaluation within 6 hours of symptom onset9, 10. Risk factor 
profile of stroke is distinct from adult stroke and is more diverse 
too. These include CNS infections, cardiac diseases 
(congenital and acquired) vasculopathies (fibromuscular 
dysplasia and moyamoya disease), vsculitidis, sickle cell 
disease, coagulopathies and arterial dissection.1,11 In a local 
study CNS Infections and cardiac diseases were most 
common etiologic factors. 12There is great variability in the 
use of antithrombotic and antiplatelet drugs after acute 
ischemic stroke (AIS) in children.13 International Pediatric 
Stroke group reported that of the 661 children with AIS, the 
acute treatment consisted of anticoagulant alone in 27%, 
antiplatelet therapy alone in 28%, and a combination of 
anticoagulation and antiplatelet therapy in 16% of patients. 
Anticoagulation was more likely to be used in children with 
dissection and cardiac disease and less likely to be used in 
patients with other risk factors 13. After an episode of cerebral 
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ischemia, children usually show substantial improvement in 
the first 2 to 3 weeks and slower progress over the next several 
months, however, many children are left with persistent 
neurologic deficits.14 About 10% of children die during acute 
period, and among the survivors, 70% are left with neurologic 
deficits15 and approximately 15% to 20% have further 
strokes.16, 17 Data on pediatric stroke from Pakistan is 
scarce. Our objective is to describe the clinical features, 
management and outcome of acute ischemic stroke in 
pediatric patients admitted in a tertiary care university hospital 
in Karachi, Pakistan.
Materials and methods:
We conducted a retrospective chart review of all cases of acute 
ischemic stroke, who were admitted in the pediatric ward of 
Aga Khan University Hospital (AKUH), Karachi, Pakistan from 
January 2007 till December 2012. Records were retrieved by 
using ICD-9 coding system through our health information 
management system. Patients aged below one month and 
above 14 years were excluded. Patients in whom imaging was 
not performed were also excluded. Other exclusion criteria 
included patients with post traumatic or post anoxic brain 
ischemia and with history of birth asphyxia, spinal and brain 
trauma, GuillanBarre syndrome, poliomyelitis, these diseases 
could result in seizures and other symptoms of interest on their 
own and that would contaminate our data. The demographic, 
clinical, laboratory, radiologic and pharmacologic data as well 
as post discharge follow up was recorded on a structured 
proforma.The data was analyzed on SPSS version 20.0 (IBM, 
Chicago, USA). Summary statistics were used to describe the 
cohort. Results were presented as mean and standard 
deviation for continuous variables and frequencies and 
percentage for categorical variables.The study was approved 
by the institutional ethics review committee.
Results:
We identified a total of 29 pediatric patients with acute 
ischemic stroke over a period of 5 years. Their mean age was 
4.52 ± 4.1 years with seventy six percent over the age of one 
year. Male to female ratio was 3:1. Mean duration of 
symptoms at the time of presentation was 5.75±11.73. 
Seizures, loss of consciousness, paresis were the commonest 
clinical presentations followed by fever, vomiting, cranial nerve 
palsy, delayed development, headache and blindness (figure 
1). Out of the 21 patients who had seizures at presentation, 
13 (62%) had generalized seizures, 7 (33%) had focal and 1 
(5%) had myoclonic seizures. The cause of ischemic stroke 
was identified in 22 patients and is shown in figure no.2. Past 
history of stroke were present in only 2 (7%) patients and 
positive family history of stroke were identified in only 1 (3.4%) 
patient.Echocardiogram was performed in 13 patients that 
revealed myocarditis in 5, tetralogy of Fallot, complex 
congenital heart disease and ventricular septal defect one in 
each. None of these patients had patent foramen ovale. 
Ejection fraction was low in 4 patients (40% in one and 
20-25% in 3). Prothrombotic workup was performed in 8 
patients and 3 of these had hypercoagulopathy (protein S 
deficiency in 2 and protein C deficiency in 1). CNS infections 
were noted in three patients (2 meningitis, 1 encephalitis), 
hematologic abnormalities noted in three patients (one each 
had hemophagiclymphohistiocytosis, thalassemia major who 
underwent bone marrow transplant and hereditary 
spherocytosis), three had vasculopathies (moyamoya in one 
and idiopathic vasculopathy in 2), 2 had possible 
mitochondrial disorders and 2 had dehydration/hypovolemia.
All patients underwent brain imaging (4 had only CT scan of 
head and 25 had either MRI brain or CT and MRI both). 
Anterior circulation strokes were seen in 16 (55%), posterior 
circulation strokes in 4 (14%) patients while in 9 (31%) 
patients both circulations were effected. Twelve (41%) had 
bilateral and 17 had (59%) unilateral strokes. Eight (28%) 
received anticoagulation and 20 (69%) received aspirin. 
Anti-seizure medications were given to 22 (76%) patients. All 
children received supportive treatment acutely, with some 
receiving physical, speech, or occupational therapy or a 
combination of rehabilitation modalities. Mean length of stay 
was 7±5 days. Eight (28%) patients died during the hospital 
stay and 21 patients were sent home.In a univariate analysis, 
multiple strokes and age below one year were associated with 
higher mortality(Table no 1). Each of the survivor had at least 
two follow up visits and their mean follow up period was  15 
+/- 9.5 months (Range: 2-35). Four patients died during 
follow up while 3 patients had complete recovery, and 14 of 
17 (82%) patientshad residual neurologic deficit (motor, 
cognitive deficits or both).
Discussion:
This study presents a detailed report of the patients who 
presented to Aga Khan University Hospital with ischemic stroke 
during a 5 year period. Mean age of our patients was 4.5±4.2 
(median 3) years and there was male predominance. An 
Indian study reported mean age of about 11 years while 
international pediatric stroke study (IPSS) reported median 
age of about 5 years.13,18 Though the age of our patients 
was relatively younger but we noted male preponderance 
which has been reported by a hospital based in India and the 
multicenter IPSS13,19 The relatively younger age group at 
presentation (mean 39 months) has been reported earlier 
from Pakistan3.  Selection bias is always a possibility in 
hospital based studies specially the retrospective ones but 
possibility of the fact that stroke in our country occurs at 
younger age cannot be excluded. In Pakistan adult stroke has 
been reported to occur about a decade earlier than that 
reported from West.20,21  We noted that cardiac disorders 
(congenital or acquired) were the most common causes of 
stroke in our patients followed by CNS infections, 
hypercoagulopathies, hematological diseases and 
vasculopathies. This finding that is consistent with previous 
reports.1, 3, 11, 12, 18, and 22 Previous studies reported 
that hemiplegia was the most common clinical presentation 
followed by seizures in such patients.3, 6, 18However; our 
data showed that seizures were more common manifestation 
followed closely by hemiplegia. One reason could be that our 
patient presented to the hospital early, before the onset of 
more advance symptoms such as hemiplegia. The treatment 
for ischemic strokes most commonly reported in other studies 
consists of anticoagulants, antiplatelets or a combination of 
both of these.13a similar strategy was noted in our patients, 
however, in IPSS anticoagulation and antiplatelet were used in 
almost equal number of the patients while most of our 
patients received antiplatelet agent. This simply reflects 
variations in stroke management among the treating 
physicians. Though there is robust evidence for specific 
treatment in stroke patients with sickle cell disease, 
moyamoya disease but for rest of patients the evidence and 
recommendations are of relatively low level.1 The mortality 
rate among our patients in acute period (during index 
hospitalization; mean hospital stay  was 7±5 days) was 28% 
which is significantly higher than earlier reports which 
mentioned mortality below 10%.13,16, 17,18 Similarly, 
post-discharge mortality of our patients was also high i.e. 14% 
of the survivors died during the mean follow up period of 
15±9.5 days. The high mortality rate is probably multifactorial. 
Most of our patients had bilateral multiple strokes which has 
been reported as poor prognostic factor.13  Cardiac disorders 
were most common etiologic factors in our patients and these 
are reported to be more frequently associated with bilateral 
strokes.22  Young age and fever at presentation have also 
been reported as poor prognostic factors in long term.23 
Mean age of our patients was relatively young comparative to 
the age reported in literature and about 40% of our patients 
had fever at presentation. Thesemight be the contributory 
factors to poor outcome in our patients. Additionally, lack of 
trained neurologists (most of pediatric stroke patients are 
managed by general pediatricians), lack of stroke units and 
lack of pediatric focused rehabilitation services, all might be 
contributory. Previous studies have reported that among the 
patients who survive after a stroke 70% has persistent 
neurological deficits.16, 17 we also noted residual neurologic 
deficits in 82% of the patients.Our study shows that clinical 
presentation, etiologic factors and prophylactic management 
is more or less similar to prior reported literature, however, 
significant differences were also noted including relatively 
younger age at onset, high immediate and long term mortality. 
The establishment of multicenter pediatric stroke database 
study in Pakistan is needed to further evaluate our findings.
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Table 1: Factors associated with acute mortality
 Factor  Mortality p value
 Age: ≤1 year vs. >1 year 5/8 (62%) vs. 3/21  0.019
 (14%)
 *Ant and post circulation 5/9 (56%) vs. 3/20 0.037
 vs. either ant or post (15%)
 circulation strokes   
 Bilateral vs. unilateral 7/12 (58%) vs. 1/17 0.003
 strokes (6%)  
 Strokes in multiple arterial 8/20 (40%) vs. 0/9 0.029
 territories vs. single artery (0%)
 strokes     
*ant: anterior, post: posterior
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Introduction:
Stroke is debilitating disease which has been increasingly 
recognized in children in recent years, but diagnosis and 
management can be difficult because of the diversity of 
underlying risk factors and the absence of a uniform treatment 
approach.1The incidence of ischemic stroke in USA ranges 
from 0.56 to 2.4 per 100,000 children per year.4In the 
Paediatric population, ischemic stroke occurs in 55% of all 
strokes, the rest being hemorrhagic4, 5. In Contrary to adults 
in whom ischemic stroke comprises 80% to 85% of all the 
strokes cases.4, 5 Though hemiplegia is most common 
clinical presentation in pediatric stroke as in adults but seizures 
and fever are more common in pediatric strokes which 
affecting 27% and 23% respectively of pediatric stroke 
patient.6 Even when stroke presents acutely, delay in 
diagnosis is common, limiting the opportunities for timely 
interventions to improve outcome.4 Thrombolysis is standard 
of care for acute ischemic stroke in adult patients which is to 
be given within 4.5 hours of stroke onset7. Though the 
experience of thrombolysis in pediatric stroke is limited but it 
has to be given early8.However, it has been reported that in 
about 1/3 of children with stroke present for medical 
evaluation within 6 hours of symptom onset9, 10. Risk factor 
profile of stroke is distinct from adult stroke and is more diverse 
too. These include CNS infections, cardiac diseases 
(congenital and acquired) vasculopathies (fibromuscular 
dysplasia and moyamoya disease), vsculitidis, sickle cell 
disease, coagulopathies and arterial dissection.1,11 In a local 
study CNS Infections and cardiac diseases were most 
common etiologic factors. 12There is great variability in the 
use of antithrombotic and antiplatelet drugs after acute 
ischemic stroke (AIS) in children.13 International Pediatric 
Stroke group reported that of the 661 children with AIS, the 
acute treatment consisted of anticoagulant alone in 27%, 
antiplatelet therapy alone in 28%, and a combination of 
anticoagulation and antiplatelet therapy in 16% of patients. 
Anticoagulation was more likely to be used in children with 
dissection and cardiac disease and less likely to be used in 
patients with other risk factors 13. After an episode of cerebral 
ischemia, children usually show substantial improvement in 
the first 2 to 3 weeks and slower progress over the next several 
months, however, many children are left with persistent 
neurologic deficits.14 About 10% of children die during acute 
period, and among the survivors, 70% are left with neurologic 
deficits15 and approximately 15% to 20% have further 
strokes.16, 17 Data on pediatric stroke from Pakistan is 
scarce. Our objective is to describe the clinical features, 
management and outcome of acute ischemic stroke in 
pediatric patients admitted in a tertiary care university hospital 
in Karachi, Pakistan.
Materials and methods:
We conducted a retrospective chart review of all cases of acute 
ischemic stroke, who were admitted in the pediatric ward of 
Aga Khan University Hospital (AKUH), Karachi, Pakistan from 
January 2007 till December 2012. Records were retrieved by 
using ICD-9 coding system through our health information 
management system. Patients aged below one month and 
above 14 years were excluded. Patients in whom imaging was 
not performed were also excluded. Other exclusion criteria 
included patients with post traumatic or post anoxic brain 
ischemia and with history of birth asphyxia, spinal and brain 
trauma, GuillanBarre syndrome, poliomyelitis, these diseases 
could result in seizures and other symptoms of interest on their 
own and that would contaminate our data. The demographic, 
clinical, laboratory, radiologic and pharmacologic data as well 
as post discharge follow up was recorded on a structured 
proforma.The data was analyzed on SPSS version 20.0 (IBM, 
Chicago, USA). Summary statistics were used to describe the 
cohort. Results were presented as mean and standard 
deviation for continuous variables and frequencies and 
percentage for categorical variables.The study was approved 
by the institutional ethics review committee.
Results:
We identified a total of 29 pediatric patients with acute 
ischemic stroke over a period of 5 years. Their mean age was 
4.52 ± 4.1 years with seventy six percent over the age of one 
year. Male to female ratio was 3:1. Mean duration of 
symptoms at the time of presentation was 5.75±11.73. 
Seizures, loss of consciousness, paresis were the commonest 
clinical presentations followed by fever, vomiting, cranial nerve 
palsy, delayed development, headache and blindness (figure 
1). Out of the 21 patients who had seizures at presentation, 
13 (62%) had generalized seizures, 7 (33%) had focal and 1 
(5%) had myoclonic seizures. The cause of ischemic stroke 
was identified in 22 patients and is shown in figure no.2. Past 
history of stroke were present in only 2 (7%) patients and 
positive family history of stroke were identified in only 1 (3.4%) 
patient.Echocardiogram was performed in 13 patients that 
revealed myocarditis in 5, tetralogy of Fallot, complex 
congenital heart disease and ventricular septal defect one in 
each. None of these patients had patent foramen ovale. 
Ejection fraction was low in 4 patients (40% in one and 
20-25% in 3). Prothrombotic workup was performed in 8 
patients and 3 of these had hypercoagulopathy (protein S 
deficiency in 2 and protein C deficiency in 1). CNS infections 
were noted in three patients (2 meningitis, 1 encephalitis), 
hematologic abnormalities noted in three patients (one each 
had hemophagiclymphohistiocytosis, thalassemia major who 
underwent bone marrow transplant and hereditary 
spherocytosis), three had vasculopathies (moyamoya in one 
and idiopathic vasculopathy in 2), 2 had possible 
mitochondrial disorders and 2 had dehydration/hypovolemia.
All patients underwent brain imaging (4 had only CT scan of 
head and 25 had either MRI brain or CT and MRI both). 
Anterior circulation strokes were seen in 16 (55%), posterior 
circulation strokes in 4 (14%) patients while in 9 (31%) 
patients both circulations were effected. Twelve (41%) had 
bilateral and 17 had (59%) unilateral strokes. Eight (28%) 
received anticoagulation and 20 (69%) received aspirin. 
Anti-seizure medications were given to 22 (76%) patients. All 
children received supportive treatment acutely, with some 
receiving physical, speech, or occupational therapy or a 
combination of rehabilitation modalities. Mean length of stay 
was 7±5 days. Eight (28%) patients died during the hospital 
stay and 21 patients were sent home.In a univariate analysis, 
multiple strokes and age below one year were associated with 
higher mortality(Table no 1). Each of the survivor had at least 
two follow up visits and their mean follow up period was  15 
+/- 9.5 months (Range: 2-35). Four patients died during 
follow up while 3 patients had complete recovery, and 14 of 
17 (82%) patientshad residual neurologic deficit (motor, 
cognitive deficits or both).
Discussion:
This study presents a detailed report of the patients who 
presented to Aga Khan University Hospital with ischemic stroke 
during a 5 year period. Mean age of our patients was 4.5±4.2 
(median 3) years and there was male predominance. An 
Indian study reported mean age of about 11 years while 
international pediatric stroke study (IPSS) reported median 
age of about 5 years.13,18 Though the age of our patients 
was relatively younger but we noted male preponderance 
which has been reported by a hospital based in India and the 
multicenter IPSS13,19 The relatively younger age group at 
presentation (mean 39 months) has been reported earlier 
from Pakistan3.  Selection bias is always a possibility in 
hospital based studies specially the retrospective ones but 
possibility of the fact that stroke in our country occurs at 
younger age cannot be excluded. In Pakistan adult stroke has 
been reported to occur about a decade earlier than that 
reported from West.20,21  We noted that cardiac disorders 
(congenital or acquired) were the most common causes of 
stroke in our patients followed by CNS infections, 
hypercoagulopathies, hematological diseases and 
vasculopathies. This finding that is consistent with previous 
reports.1, 3, 11, 12, 18, and 22 Previous studies reported 
that hemiplegia was the most common clinical presentation 
followed by seizures in such patients.3, 6, 18However; our 
data showed that seizures were more common manifestation 
followed closely by hemiplegia. One reason could be that our 
patient presented to the hospital early, before the onset of 
more advance symptoms such as hemiplegia. The treatment 
for ischemic strokes most commonly reported in other studies 
consists of anticoagulants, antiplatelets or a combination of 
both of these.13a similar strategy was noted in our patients, 
however, in IPSS anticoagulation and antiplatelet were used in 
almost equal number of the patients while most of our 
patients received antiplatelet agent. This simply reflects 
variations in stroke management among the treating 
physicians. Though there is robust evidence for specific 
treatment in stroke patients with sickle cell disease, 
moyamoya disease but for rest of patients the evidence and 
recommendations are of relatively low level.1 The mortality 
rate among our patients in acute period (during index 
hospitalization; mean hospital stay  was 7±5 days) was 28% 
which is significantly higher than earlier reports which 
mentioned mortality below 10%.13,16, 17,18 Similarly, 
post-discharge mortality of our patients was also high i.e. 14% 
of the survivors died during the mean follow up period of 
15±9.5 days. The high mortality rate is probably multifactorial. 
Most of our patients had bilateral multiple strokes which has 
been reported as poor prognostic factor.13  Cardiac disorders 
were most common etiologic factors in our patients and these 
are reported to be more frequently associated with bilateral 
strokes.22  Young age and fever at presentation have also 
been reported as poor prognostic factors in long term.23 
Mean age of our patients was relatively young comparative to 
the age reported in literature and about 40% of our patients 
had fever at presentation. Thesemight be the contributory 
factors to poor outcome in our patients. Additionally, lack of 
trained neurologists (most of pediatric stroke patients are 
managed by general pediatricians), lack of stroke units and 
lack of pediatric focused rehabilitation services, all might be 
contributory. Previous studies have reported that among the 
patients who survive after a stroke 70% has persistent 
neurological deficits.16, 17 we also noted residual neurologic 
deficits in 82% of the patients.Our study shows that clinical 
presentation, etiologic factors and prophylactic management 
is more or less similar to prior reported literature, however, 
significant differences were also noted including relatively 
younger age at onset, high immediate and long term mortality. 
The establishment of multicenter pediatric stroke database 
study in Pakistan is needed to further evaluate our findings.
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Table 1: Factors associated with acute mortality
 Factor  Mortality p value
 Age: ≤1 year vs. >1 year 5/8 (62%) vs. 3/21  0.019
 (14%)
 *Ant and post circulation 5/9 (56%) vs. 3/20 0.037
 vs. either ant or post (15%)
 circulation strokes   
 Bilateral vs. unilateral 7/12 (58%) vs. 1/17 0.003
 strokes (6%)  
 Strokes in multiple arterial 8/20 (40%) vs. 0/9 0.029
 territories vs. single artery (0%)
 strokes     
*ant: anterior, post: posterior
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Introduction:
Stroke is debilitating disease which has been increasingly 
recognized in children in recent years, but diagnosis and 
management can be difficult because of the diversity of 
underlying risk factors and the absence of a uniform treatment 
approach.1The incidence of ischemic stroke in USA ranges 
from 0.56 to 2.4 per 100,000 children per year.4In the 
Paediatric population, ischemic stroke occurs in 55% of all 
strokes, the rest being hemorrhagic4, 5. In Contrary to adults 
in whom ischemic stroke comprises 80% to 85% of all the 
strokes cases.4, 5 Though hemiplegia is most common 
clinical presentation in pediatric stroke as in adults but seizures 
and fever are more common in pediatric strokes which 
affecting 27% and 23% respectively of pediatric stroke 
patient.6 Even when stroke presents acutely, delay in 
diagnosis is common, limiting the opportunities for timely 
interventions to improve outcome.4 Thrombolysis is standard 
of care for acute ischemic stroke in adult patients which is to 
be given within 4.5 hours of stroke onset7. Though the 
experience of thrombolysis in pediatric stroke is limited but it 
has to be given early8.However, it has been reported that in 
about 1/3 of children with stroke present for medical 
evaluation within 6 hours of symptom onset9, 10. Risk factor 
profile of stroke is distinct from adult stroke and is more diverse 
too. These include CNS infections, cardiac diseases 
(congenital and acquired) vasculopathies (fibromuscular 
dysplasia and moyamoya disease), vsculitidis, sickle cell 
disease, coagulopathies and arterial dissection.1,11 In a local 
study CNS Infections and cardiac diseases were most 
common etiologic factors. 12There is great variability in the 
use of antithrombotic and antiplatelet drugs after acute 
ischemic stroke (AIS) in children.13 International Pediatric 
Stroke group reported that of the 661 children with AIS, the 
acute treatment consisted of anticoagulant alone in 27%, 
antiplatelet therapy alone in 28%, and a combination of 
anticoagulation and antiplatelet therapy in 16% of patients. 
Anticoagulation was more likely to be used in children with 
dissection and cardiac disease and less likely to be used in 
patients with other risk factors 13. After an episode of cerebral 
ischemia, children usually show substantial improvement in 
the first 2 to 3 weeks and slower progress over the next several 
months, however, many children are left with persistent 
neurologic deficits.14 About 10% of children die during acute 
period, and among the survivors, 70% are left with neurologic 
deficits15 and approximately 15% to 20% have further 
strokes.16, 17 Data on pediatric stroke from Pakistan is 
scarce. Our objective is to describe the clinical features, 
management and outcome of acute ischemic stroke in 
pediatric patients admitted in a tertiary care university hospital 
in Karachi, Pakistan.
Materials and methods:
We conducted a retrospective chart review of all cases of acute 
ischemic stroke, who were admitted in the pediatric ward of 
Aga Khan University Hospital (AKUH), Karachi, Pakistan from 
January 2007 till December 2012. Records were retrieved by 
using ICD-9 coding system through our health information 
management system. Patients aged below one month and 
above 14 years were excluded. Patients in whom imaging was 
not performed were also excluded. Other exclusion criteria 
included patients with post traumatic or post anoxic brain 
ischemia and with history of birth asphyxia, spinal and brain 
trauma, GuillanBarre syndrome, poliomyelitis, these diseases 
could result in seizures and other symptoms of interest on their 
own and that would contaminate our data. The demographic, 
clinical, laboratory, radiologic and pharmacologic data as well 
as post discharge follow up was recorded on a structured 
proforma.The data was analyzed on SPSS version 20.0 (IBM, 
Chicago, USA). Summary statistics were used to describe the 
cohort. Results were presented as mean and standard 
deviation for continuous variables and frequencies and 
percentage for categorical variables.The study was approved 
by the institutional ethics review committee.
Results:
We identified a total of 29 pediatric patients with acute 
ischemic stroke over a period of 5 years. Their mean age was 
4.52 ± 4.1 years with seventy six percent over the age of one 
year. Male to female ratio was 3:1. Mean duration of 
symptoms at the time of presentation was 5.75±11.73. 
Seizures, loss of consciousness, paresis were the commonest 
clinical presentations followed by fever, vomiting, cranial nerve 
palsy, delayed development, headache and blindness (figure 
1). Out of the 21 patients who had seizures at presentation, 
13 (62%) had generalized seizures, 7 (33%) had focal and 1 
(5%) had myoclonic seizures. The cause of ischemic stroke 
was identified in 22 patients and is shown in figure no.2. Past 
history of stroke were present in only 2 (7%) patients and 
positive family history of stroke were identified in only 1 (3.4%) 
patient.Echocardiogram was performed in 13 patients that 
revealed myocarditis in 5, tetralogy of Fallot, complex 
congenital heart disease and ventricular septal defect one in 
each. None of these patients had patent foramen ovale. 
Ejection fraction was low in 4 patients (40% in one and 
20-25% in 3). Prothrombotic workup was performed in 8 
patients and 3 of these had hypercoagulopathy (protein S 
deficiency in 2 and protein C deficiency in 1). CNS infections 
were noted in three patients (2 meningitis, 1 encephalitis), 
hematologic abnormalities noted in three patients (one each 
had hemophagiclymphohistiocytosis, thalassemia major who 
underwent bone marrow transplant and hereditary 
spherocytosis), three had vasculopathies (moyamoya in one 
and idiopathic vasculopathy in 2), 2 had possible 
mitochondrial disorders and 2 had dehydration/hypovolemia.
All patients underwent brain imaging (4 had only CT scan of 
head and 25 had either MRI brain or CT and MRI both). 
Anterior circulation strokes were seen in 16 (55%), posterior 
circulation strokes in 4 (14%) patients while in 9 (31%) 
patients both circulations were effected. Twelve (41%) had 
bilateral and 17 had (59%) unilateral strokes. Eight (28%) 
received anticoagulation and 20 (69%) received aspirin. 
Anti-seizure medications were given to 22 (76%) patients. All 
children received supportive treatment acutely, with some 
receiving physical, speech, or occupational therapy or a 
combination of rehabilitation modalities. Mean length of stay 
was 7±5 days. Eight (28%) patients died during the hospital 
stay and 21 patients were sent home.In a univariate analysis, 
multiple strokes and age below one year were associated with 
higher mortality(Table no 1). Each of the survivor had at least 
two follow up visits and their mean follow up period was  15 
+/- 9.5 months (Range: 2-35). Four patients died during 
follow up while 3 patients had complete recovery, and 14 of 
17 (82%) patientshad residual neurologic deficit (motor, 
cognitive deficits or both).
Discussion:
This study presents a detailed report of the patients who 
presented to Aga Khan University Hospital with ischemic stroke 
during a 5 year period. Mean age of our patients was 4.5±4.2 
(median 3) years and there was male predominance. An 
Indian study reported mean age of about 11 years while 
international pediatric stroke study (IPSS) reported median 
age of about 5 years.13,18 Though the age of our patients 
was relatively younger but we noted male preponderance 
which has been reported by a hospital based in India and the 
multicenter IPSS13,19 The relatively younger age group at 
presentation (mean 39 months) has been reported earlier 
from Pakistan3.  Selection bias is always a possibility in 
hospital based studies specially the retrospective ones but 
possibility of the fact that stroke in our country occurs at 
younger age cannot be excluded. In Pakistan adult stroke has 
been reported to occur about a decade earlier than that 
reported from West.20,21  We noted that cardiac disorders 
(congenital or acquired) were the most common causes of 
stroke in our patients followed by CNS infections, 
hypercoagulopathies, hematological diseases and 
vasculopathies. This finding that is consistent with previous 
reports.1, 3, 11, 12, 18, and 22 Previous studies reported 
that hemiplegia was the most common clinical presentation 
followed by seizures in such patients.3, 6, 18However; our 
data showed that seizures were more common manifestation 
followed closely by hemiplegia. One reason could be that our 
patient presented to the hospital early, before the onset of 
more advance symptoms such as hemiplegia. The treatment 
for ischemic strokes most commonly reported in other studies 
consists of anticoagulants, antiplatelets or a combination of 
both of these.13a similar strategy was noted in our patients, 
however, in IPSS anticoagulation and antiplatelet were used in 
almost equal number of the patients while most of our 
patients received antiplatelet agent. This simply reflects 
variations in stroke management among the treating 
physicians. Though there is robust evidence for specific 
treatment in stroke patients with sickle cell disease, 
moyamoya disease but for rest of patients the evidence and 
recommendations are of relatively low level.1 The mortality 
rate among our patients in acute period (during index 
hospitalization; mean hospital stay  was 7±5 days) was 28% 
which is significantly higher than earlier reports which 
mentioned mortality below 10%.13,16, 17,18 Similarly, 
post-discharge mortality of our patients was also high i.e. 14% 
of the survivors died during the mean follow up period of 
15±9.5 days. The high mortality rate is probably multifactorial. 
Most of our patients had bilateral multiple strokes which has 
been reported as poor prognostic factor.13  Cardiac disorders 
were most common etiologic factors in our patients and these 
are reported to be more frequently associated with bilateral 
strokes.22  Young age and fever at presentation have also 
been reported as poor prognostic factors in long term.23 
Mean age of our patients was relatively young comparative to 
the age reported in literature and about 40% of our patients 
had fever at presentation. Thesemight be the contributory 
factors to poor outcome in our patients. Additionally, lack of 
trained neurologists (most of pediatric stroke patients are 
managed by general pediatricians), lack of stroke units and 
lack of pediatric focused rehabilitation services, all might be 
contributory. Previous studies have reported that among the 
patients who survive after a stroke 70% has persistent 
neurological deficits.16, 17 we also noted residual neurologic 
deficits in 82% of the patients.Our study shows that clinical 
presentation, etiologic factors and prophylactic management 
is more or less similar to prior reported literature, however, 
significant differences were also noted including relatively 
younger age at onset, high immediate and long term mortality. 
The establishment of multicenter pediatric stroke database 
study in Pakistan is needed to further evaluate our findings.
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Table 1: Factors associated with acute mortality
 Factor  Mortality p value
 Age: ≤1 year vs. >1 year 5/8 (62%) vs. 3/21  0.019
 (14%)
 *Ant and post circulation 5/9 (56%) vs. 3/20 0.037
 vs. either ant or post (15%)
 circulation strokes   
 Bilateral vs. unilateral 7/12 (58%) vs. 1/17 0.003
 strokes (6%)  
 Strokes in multiple arterial 8/20 (40%) vs. 0/9 0.029
 territories vs. single artery (0%)
 strokes     
*ant: anterior, post: posterior
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Introduction:
Stroke is debilitating disease which has been increasingly 
recognized in children in recent years, but diagnosis and 
management can be difficult because of the diversity of 
underlying risk factors and the absence of a uniform treatment 
approach.1The incidence of ischemic stroke in USA ranges 
from 0.56 to 2.4 per 100,000 children per year.4In the 
Paediatric population, ischemic stroke occurs in 55% of all 
strokes, the rest being hemorrhagic4, 5. In Contrary to adults 
in whom ischemic stroke comprises 80% to 85% of all the 
strokes cases.4, 5 Though hemiplegia is most common 
clinical presentation in pediatric stroke as in adults but seizures 
and fever are more common in pediatric strokes which 
affecting 27% and 23% respectively of pediatric stroke 
patient.6 Even when stroke presents acutely, delay in 
diagnosis is common, limiting the opportunities for timely 
interventions to improve outcome.4 Thrombolysis is standard 
of care for acute ischemic stroke in adult patients which is to 
be given within 4.5 hours of stroke onset7. Though the 
experience of thrombolysis in pediatric stroke is limited but it 
has to be given early8.However, it has been reported that in 
about 1/3 of children with stroke present for medical 
evaluation within 6 hours of symptom onset9, 10. Risk factor 
profile of stroke is distinct from adult stroke and is more diverse 
too. These include CNS infections, cardiac diseases 
(congenital and acquired) vasculopathies (fibromuscular 
dysplasia and moyamoya disease), vsculitidis, sickle cell 
disease, coagulopathies and arterial dissection.1,11 In a local 
study CNS Infections and cardiac diseases were most 
common etiologic factors. 12There is great variability in the 
use of antithrombotic and antiplatelet drugs after acute 
ischemic stroke (AIS) in children.13 International Pediatric 
Stroke group reported that of the 661 children with AIS, the 
acute treatment consisted of anticoagulant alone in 27%, 
antiplatelet therapy alone in 28%, and a combination of 
anticoagulation and antiplatelet therapy in 16% of patients. 
Anticoagulation was more likely to be used in children with 
dissection and cardiac disease and less likely to be used in 
patients with other risk factors 13. After an episode of cerebral 
ischemia, children usually show substantial improvement in 
the first 2 to 3 weeks and slower progress over the next several 
months, however, many children are left with persistent 
neurologic deficits.14 About 10% of children die during acute 
period, and among the survivors, 70% are left with neurologic 
deficits15 and approximately 15% to 20% have further 
strokes.16, 17 Data on pediatric stroke from Pakistan is 
scarce. Our objective is to describe the clinical features, 
management and outcome of acute ischemic stroke in 
pediatric patients admitted in a tertiary care university hospital 
in Karachi, Pakistan.
Materials and methods:
We conducted a retrospective chart review of all cases of acute 
ischemic stroke, who were admitted in the pediatric ward of 
Aga Khan University Hospital (AKUH), Karachi, Pakistan from 
January 2007 till December 2012. Records were retrieved by 
using ICD-9 coding system through our health information 
management system. Patients aged below one month and 
above 14 years were excluded. Patients in whom imaging was 
not performed were also excluded. Other exclusion criteria 
included patients with post traumatic or post anoxic brain 
ischemia and with history of birth asphyxia, spinal and brain 
trauma, GuillanBarre syndrome, poliomyelitis, these diseases 
could result in seizures and other symptoms of interest on their 
own and that would contaminate our data. The demographic, 
clinical, laboratory, radiologic and pharmacologic data as well 
as post discharge follow up was recorded on a structured 
proforma.The data was analyzed on SPSS version 20.0 (IBM, 
Chicago, USA). Summary statistics were used to describe the 
cohort. Results were presented as mean and standard 
deviation for continuous variables and frequencies and 
percentage for categorical variables.The study was approved 
by the institutional ethics review committee.
Results:
We identified a total of 29 pediatric patients with acute 
ischemic stroke over a period of 5 years. Their mean age was 
4.52 ± 4.1 years with seventy six percent over the age of one 
year. Male to female ratio was 3:1. Mean duration of 
symptoms at the time of presentation was 5.75±11.73. 
Seizures, loss of consciousness, paresis were the commonest 
clinical presentations followed by fever, vomiting, cranial nerve 
palsy, delayed development, headache and blindness (figure 
1). Out of the 21 patients who had seizures at presentation, 
13 (62%) had generalized seizures, 7 (33%) had focal and 1 
(5%) had myoclonic seizures. The cause of ischemic stroke 
was identified in 22 patients and is shown in figure no.2. Past 
history of stroke were present in only 2 (7%) patients and 
positive family history of stroke were identified in only 1 (3.4%) 
patient.Echocardiogram was performed in 13 patients that 
revealed myocarditis in 5, tetralogy of Fallot, complex 
congenital heart disease and ventricular septal defect one in 
each. None of these patients had patent foramen ovale. 
Ejection fraction was low in 4 patients (40% in one and 
20-25% in 3). Prothrombotic workup was performed in 8 
patients and 3 of these had hypercoagulopathy (protein S 
deficiency in 2 and protein C deficiency in 1). CNS infections 
were noted in three patients (2 meningitis, 1 encephalitis), 
hematologic abnormalities noted in three patients (one each 
had hemophagiclymphohistiocytosis, thalassemia major who 
underwent bone marrow transplant and hereditary 
spherocytosis), three had vasculopathies (moyamoya in one 
and idiopathic vasculopathy in 2), 2 had possible 
mitochondrial disorders and 2 had dehydration/hypovolemia.
All patients underwent brain imaging (4 had only CT scan of 
head and 25 had either MRI brain or CT and MRI both). 
Anterior circulation strokes were seen in 16 (55%), posterior 
circulation strokes in 4 (14%) patients while in 9 (31%) 
patients both circulations were effected. Twelve (41%) had 
bilateral and 17 had (59%) unilateral strokes. Eight (28%) 
received anticoagulation and 20 (69%) received aspirin. 
Anti-seizure medications were given to 22 (76%) patients. All 
children received supportive treatment acutely, with some 
receiving physical, speech, or occupational therapy or a 
combination of rehabilitation modalities. Mean length of stay 
was 7±5 days. Eight (28%) patients died during the hospital 
stay and 21 patients were sent home.In a univariate analysis, 
multiple strokes and age below one year were associated with 
higher mortality(Table no 1). Each of the survivor had at least 
two follow up visits and their mean follow up period was  15 
+/- 9.5 months (Range: 2-35). Four patients died during 
follow up while 3 patients had complete recovery, and 14 of 
17 (82%) patientshad residual neurologic deficit (motor, 
cognitive deficits or both).
Discussion:
This study presents a detailed report of the patients who 
presented to Aga Khan University Hospital with ischemic stroke 
during a 5 year period. Mean age of our patients was 4.5±4.2 
(median 3) years and there was male predominance. An 
Indian study reported mean age of about 11 years while 
international pediatric stroke study (IPSS) reported median 
age of about 5 years.13,18 Though the age of our patients 
was relatively younger but we noted male preponderance 
which has been reported by a hospital based in India and the 
multicenter IPSS13,19 The relatively younger age group at 
presentation (mean 39 months) has been reported earlier 
from Pakistan3.  Selection bias is always a possibility in 
hospital based studies specially the retrospective ones but 
possibility of the fact that stroke in our country occurs at 
younger age cannot be excluded. In Pakistan adult stroke has 
been reported to occur about a decade earlier than that 
reported from West.20,21  We noted that cardiac disorders 
(congenital or acquired) were the most common causes of 
stroke in our patients followed by CNS infections, 
hypercoagulopathies, hematological diseases and 
vasculopathies. This finding that is consistent with previous 
reports.1, 3, 11, 12, 18, and 22 Previous studies reported 
that hemiplegia was the most common clinical presentation 
followed by seizures in such patients.3, 6, 18However; our 
data showed that seizures were more common manifestation 
followed closely by hemiplegia. One reason could be that our 
patient presented to the hospital early, before the onset of 
more advance symptoms such as hemiplegia. The treatment 
for ischemic strokes most commonly reported in other studies 
consists of anticoagulants, antiplatelets or a combination of 
both of these.13a similar strategy was noted in our patients, 
however, in IPSS anticoagulation and antiplatelet were used in 
almost equal number of the patients while most of our 
patients received antiplatelet agent. This simply reflects 
variations in stroke management among the treating 
physicians. Though there is robust evidence for specific 
treatment in stroke patients with sickle cell disease, 
moyamoya disease but for rest of patients the evidence and 
recommendations are of relatively low level.1 The mortality 
rate among our patients in acute period (during index 
hospitalization; mean hospital stay  was 7±5 days) was 28% 
which is significantly higher than earlier reports which 
mentioned mortality below 10%.13,16, 17,18 Similarly, 
post-discharge mortality of our patients was also high i.e. 14% 
of the survivors died during the mean follow up period of 
15±9.5 days. The high mortality rate is probably multifactorial. 
Most of our patients had bilateral multiple strokes which has 
been reported as poor prognostic factor.13  Cardiac disorders 
were most common etiologic factors in our patients and these 
are reported to be more frequently associated with bilateral 
strokes.22  Young age and fever at presentation have also 
been reported as poor prognostic factors in long term.23 
Mean age of our patients was relatively young comparative to 
the age reported in literature and about 40% of our patients 
had fever at presentation. Thesemight be the contributory 
factors to poor outcome in our patients. Additionally, lack of 
trained neurologists (most of pediatric stroke patients are 
managed by general pediatricians), lack of stroke units and 
lack of pediatric focused rehabilitation services, all might be 
contributory. Previous studies have reported that among the 
patients who survive after a stroke 70% has persistent 
neurological deficits.16, 17 we also noted residual neurologic 
deficits in 82% of the patients.Our study shows that clinical 
presentation, etiologic factors and prophylactic management 
is more or less similar to prior reported literature, however, 
significant differences were also noted including relatively 
younger age at onset, high immediate and long term mortality. 
The establishment of multicenter pediatric stroke database 
study in Pakistan is needed to further evaluate our findings.
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Table 1: Factors associated with acute mortality
 Factor  Mortality p value
 Age: ≤1 year vs. >1 year 5/8 (62%) vs. 3/21  0.019
 (14%)
 *Ant and post circulation 5/9 (56%) vs. 3/20 0.037
 vs. either ant or post (15%)
 circulation strokes   
 Bilateral vs. unilateral 7/12 (58%) vs. 1/17 0.003
 strokes (6%)  
 Strokes in multiple arterial 8/20 (40%) vs. 0/9 0.029
 territories vs. single artery (0%)
 strokes     
*ant: anterior, post: posterior
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